Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor and stress in rats

• Published in: Digestive diseases and sciences Vol. 33; no. 7; p. 806
• Main Authors: Konturek, S J, Brzozowski, T, Drozdowicz, D, Beck, G
• Format: Journal Article
• Language: English
• Published: United States 01.07.1988
• Subjects: Animals; Aspirin - toxicity; Chromones - pharmacology; Dinoprostone; Ethanol - toxicity; Female; Gastric Mucosa - drug effects; Male; Platelet Activating Factor; Prostaglandins E - biosynthesis; Rats; Rats, Inbred Strains; SRS-A - antagonists & inhibitors; SRS-A - physiology; Stomach Ulcer - etiology; Stress, Physiological - complications; Taurocholic Acid - toxicity
• ISSN: 0163-2116
• DOI: 10.1007/BF01550967

This study was designed to determine the role of leukotriene C4 (LTC4) in the formation of acute gastric lesions induced by 100% ethanol, acidified taurocholate (TC), acidified aspirin (ASA), platelet-activating factor (PAF), and water-immersion and restraint stress. Exogenous LTC4 alone administered in gradually increasing doses (5-20 micrograms/kg/hr) caused only mild hemorrhagic lesions in the gastric mucosa but when combined with 100% ethanol, acidified TC, acidified ASA, or stress, it increased significantly the mean lesion area and lesion number as compared to those produced by these ulcerogens alone. FPL 55712, a LTC4 antagonist, given orally (2.5-10 mg/kg) reduced dose-dependently the extent of gastric lesions in all experimental models used and completely prevented the deleterious effects of exogenous LTC4 on gastric mucosa. PAF augmented the mucosal lesions induced by 100% ethanol, and this was also reduced by the pretreatment with FPL 55712. FPL 55712-induced gastroprotection against various ulcerogens was reversed, in part, by indomethacin, indicating that it could be attributed not only to the LTC4 antagonism but also to increased biosynthesis of PGs. This study provides evidence that LTC4 is involved in the formation of acute gastric damage and the antagonism of LTC4 may protect the mucosa against various ulcerogens.